Results 41 to 50 of about 514 (108)

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol. [PDF]

open access: yesAddict Sci Clin Pract
Freet CS   +14 more
europepmc   +1 more source

A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer. [PDF]

open access: yesCancer Biol Med, 2022
Zhang X   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy